Zerostack Corp. current report, Q4 FY2021

Form 6-K Summary

Registrant: Flora Growth Corp. The request metadata identifies “Zerostack Corp.,” but the filing identifies Flora Growth Corp. as the registrant.

Reporting period: Form 6-K for November 2021, filed November 19, 2021.

Business Context and Transaction

On November 18, 2021, Flora Growth entered into an underwriting agreement with A.G.P./Alliance Global Partners for a public offering of 10,000,000 units. Each unit consists of one common share and one-half warrant.

  • Offering price: $3.00 per unit.
  • Implied gross offering proceeds: approximately $30.0 million, before underwriting discounts, commissions, and offering expenses.
  • Unit warrants: approximately 5,000,000 whole warrants in aggregate, with an exercise price of $3.75 per share.
  • Warrants are immediately exercisable and expire five years after issuance.
  • Underwriters have a 45-day option to purchase up to an additional 15% of the offered units solely to cover over-allotments.

Financial Metrics and Liquidity

This filing does not provide revenue, profit, cash flow, margins, debt, or other operating financial metrics.

The offering is expected to provide approximately $30.0 million of gross capital before transaction costs, subject to closing. The filing does not state net proceeds or specify the intended use of proceeds in the provided text.

Material Changes Versus Prior Period

No comparable-period financial results or operating changes are disclosed. The material event reported is the pricing and proposed closing of the public offering.

Outlook, Risks, and Unusual Items

  • Closing was expected on November 23, 2021, subject to customary closing conditions; the filing does not confirm that the closing occurred.
  • The transaction will result in issuance of common shares and warrants, creating potential dilution to existing shareholders.
  • Additional dilution could result if the over-allotment option is exercised or if warrants are exercised.
  • The offering was conducted under an effective Form F-1 registration statement, File No. 333-261123.
  • The filing incorporates the underwriting agreement and furnishes a November 19, 2021 press release announcing the offering pricing.

Investor Verification Points

  • Verify whether the offering closed and the final number of units issued.
  • Verify net proceeds after underwriting discounts, commissions, and expenses.
  • Review the underwriting agreement for indemnification, termination, and other closing provisions.
  • Assess the potential dilution from the offered shares, over-allotment option, and warrants.
  • Review subsequent filings for the use of proceeds and the company’s liquidity following the offering.